Skip to main content
Drug Name R.COVI COVID-19 Vaccine
Drug Class
Risk minimization type
Direct Healthcare Professional Communication DHPC
Specialty (Theraputic area)
Risk

R-COVI/COVID-19 Vaccine AstraZeneca: contraindication in individuals with previous capillary leak syndrome

Dear Healthcare provider letter DHPC